DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Brimonidine (Brimonidine Tartrate Ophthalmic) - Indications and Dosage

 
 



INDICATIONS AND USAGE

Brimonidine tartrate ophthalmic solution 0.2% is indicated for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The lOP lowering efficacy of brimonidine tartrate ophthalmic solution 0.2% diminishes over time in some patients. This loss of effect appears with a variable time of onset in each patient and should be closely monitored.

DOSAGE AND ADMINISTRATION

The recommended dose is one drop of brimonidine tartrate ophthalmic solution 0.2% in the affected eye(s) three times daily, approximately 8 hours apart.

Brimonidine tartrate ophthalmic solution 0.2% may be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure. If more than one topical ophthalmic product is being used, the products should be administered at least 5 minutes apart.

HOW SUPPLIED

Brimonidine Tartrate Ophthalmic Solution 0.2% is supplied sterile in a plastic bottle with a controlled drop tip in the following sizes:

5 mL bottles – NDC 24208-411-05

10 mL bottles – NDC 24208-411-10

15 mL bottles – NDC 24208-411-15

Storage: Store between 15° – 25°C (59° – 77°F).

KEEP OUT OF THE REACH OF CHILDREN.

DO NOT USE IF IMPRINTED “Protective Seal” WITH YELLOW

IS NOT INTACT.

Revised: November 2012

Bausch & Lomb Incorporated
Tampa, FL 33637

©Bausch & Lomb Incorporated

9104702 (Folded) 9104602 (Flat)
Prod. No. 411

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017